 LexaGene Holdings Inc TSX-V:LXG, OTCQB:LXXGF, a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing, announced three additional purchase orders for MiQLab Systems from veterinary clinics in Michigan, Minnesota, and New York. In a statement, Julie Griggs, who is global director of sales at LexaGene, said: My team is diligently engaged with numerous veterinary practices, both private and corporate. 